Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Junbiao Hang is a pioneering thoracic surgeon whose research centers on robotic-assisted and video-assisted minimally invasive surgeries for thoracic malignancies. His major contributions lie in rigorously comparing these advanced techniques for lung cancer and esophageal cancer treatment. His landmark 2021 study on robotic-assisted versus video-assisted thoracoscopic lobectomy (116 citations) provided critical early evidence on perioperative outcomes and long-term efficacy in non-small-cell lung cancer (NSCLC). Dr. Hang further advanced the field with a propensity score-matched study on robot-assisted versus thoracoscopic Ivor Lewis esophagectomy (83 citations), demonstrating improved early outcomes for esophageal cancer patients. His foundational work includes reporting the initial experience of robot-assisted Ivor-Lewis esophagectomy (26 citations), detailing technical innovations for intrathoracic anastomosis. Most notably, Dr. Hang led the RVlob randomized controlled trial (2024, 19 citations), the first of its kind to prospectively compare robotic-assisted and video-assisted lobectomy for resectable NSCLC, setting a new standard for evidence-based surgical decision-making. His cumulative work has profoundly shaped modern thoracic oncology, establishing benchmarks for minimally invasive surgical efficacy and patient safety.